SB 25-121 CO

0likes☆Favorite🔕SubscribeShare

Passed One Chamber

Beginning July 1, 2025 No later than January 1, 2026 , the bill requires the department of health care policy and financing (HCPF) to seek federal authorization to reimburse acute care hospitals and ambulatory surgery facilities that provide vagus nerve stimulation therapy to members diagnosed with drug-resistant epilepsy at a rate that is equal to 75% 60% of the cost for acquiring the vagus nerve stimulator device, which reimbursement is in addition to and does not supplant the reimbursement for any necessary surgical procedure associated with implanting the device. Beginning January 1, 2029, the bill requires HCPF to increase the reimbursement to a rate that is equal to 75% of the cost for acquiring the vagus nerve simulator device. (Note: Italicized words indicate new material added to the original summary; dashes through words indicate deletions from the original summary.) (Note: This summary applies to the reengrossed version of this bill as introduced in the second house.)

• Iman Jodeh Democratic · primary
• Kyle Mullica Democratic · primary
• Lindsay Gilchrist Democratic · primary

1. Apr 28, 2025 House Committee on Health & Human Services Postpone Indefinitely · lower
2. Apr 23, 2025 Introduced In House - Assigned to Health & Human Services · lower
3. Apr 23, 2025 Senate Third Reading Passed - No Amendments · upper
4. Apr 22, 2025 Senate Second Reading Special Order - Passed with Amendments - Committee · upper
5. Apr 22, 2025 Senate Committee on Appropriations Refer Amended - Consent Calendar to Senate Committee of the Whole · upper
6. Feb 20, 2025 Senate Committee on Health & Human Services Refer Amended to Appropriations · upper
7. Feb 4, 2025 Introduced In Senate - Assigned to Health & Human Services · upper